Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

The standard of care for most patients with non-muscle-invasive bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Guérin (BCG), which activates the immune system to recognize and destroy malignant cells and has demonstrated durable clinical benefit. Urologic best-practice g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Kamat, Ashish M., Bellmunt, Joaquim, Galsky, Matthew D., Konety, Badrinath R., Lamm, Donald L., Langham, David, Lee, Cheryl T., Milowsky, Matthew I., O’Donnell, Michael A., O’Donnell, Peter H., Petrylak, Daniel P., Sharma, Padmanee, Skinner, Eila C., Sonpavde, Guru, Taylor, John A., Abraham, Prasanth, Rosenberg, Jonathan E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Position Article and Guidelines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557323/
https://ncbi.nlm.nih.gov/pubmed/28807024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0271-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados